ImmunoGen, Inc.: how funds voted at the meeting of 31 Jan 2024
- Meeting
- Season
- year to 30 June 2024
- Filers reporting
- 431
- Ballot items
- 4
431 filers on Form N-PX reported votes at the ImmunoGen, Inc. meeting of 31 Jan 2024. The records fall into 4 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.
This meeting is in the year to 30 June 2024. The latest season on file is the year to 30 June 2026. The page of ImmunoGen, Inc. has the latest meeting.
If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.
The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .
The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.
The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.
The page gives records. It gives no investment advice and no advice on how to vote.
Season on this page: year to 30 June 2024. Filings read through . How the figures are made
The ballot
Item 1: Advisory vote on executive pay (say-on-pay)
601 vote records from 415 filers. 295 of the 396 filers that marked the item voted against management. 19 filers gave no management mark.
2 filers reported share counts too large for the holding. The share split leaves those figures out; the counts of filers keep them. The rule
- Positions of 46 fund families
- For 3
- Against 40
- Abstain or withhold 3
- Against management 43
Item 2: Advisory vote on pay tied to a merger or sale
10 vote records from 9 filers. 4 of the 9 filers that marked the item voted against management.
- Positions of one fund family
- Against 1
- Against management 1
Item 3: EXTRAORDINARY TRANSACTIONS: management items
The company's items in this category are shown together, because filers word and number them differently.
216 vote records from 112 filers. 1 of the 112 filers that marked the item voted against management.
- Positions of 39 fund families
- For 38
- Abstain or withhold 1
- Against management 1
Item 4: CORPORATE GOVERNANCE: management items
The company's items in this category are shown together, because filers word and number them differently.
292 vote records from 136 filers. 14 of the 136 filers that marked the item voted against management.
- Positions of 42 fund families
- For 35
- Against 6
- Abstain or withhold 1
- Against management 7
Positions of the fund families
A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.
KeyForAgainstAbstain or withholdSplit or no voteAgainst management
| Fund family | 1. Say-on-pay | 2. Merger pay |
|---|---|---|
| AllianceBernstein | Against, against management | No report |
| American Century | Against, against management | No report |
| Artisan Partners | Against, against management | No report |
| Baird | Against, against management | No report |
| BlackRock and iShares | Against, against management | No report |
| BNY Mellon | Against, against management | No report |
| Brighthouse Funds | Against, against management | No report |
| Charles Schwab | Against, against management | No report |
| Columbia Threadneedle | Against, against management | No report |
| Dimensional | Against, against management | No report |
| DWS | Against, against management | No report |
| Equitable | Against, against management | No report |
| Fidelity | Against, against management | No report |
| First Trust | Against, against management | No report |
| Franklin Templeton | Abstain, against management | No report |
| Global X | Against, against management | No report |
| Goldman Sachs | Against, against management | No report |
| Guggenheim and Rydex | Against, against management | No report |
| Hartford Funds | Against, against management | No report |
| Invesco | Against, against management | No report |
| J.P. Morgan | Against, against management | Against, against management |
| Jackson National funds | Against, against management | No report |
| Janus Henderson | Abstain, against management | No report |
| John Hancock and Manulife | Against, against management | No report |
| Lincoln Financial | Against, against management | No report |
| Lord Abbett | Against, against management | No report |
| MassMutual | Against, against management | No report |
| Morgan Stanley, Eaton Vance and Calvert | Against, against management | No report |
| Nationwide | Against, against management | No report |
| Natixis and Loomis Sayles | Against, against management | No report |
| Neuberger Berman | For | No report |
| Northern Trust and FlexShares | Against, against management | No report |
| Nuveen and TIAA | Against, against management | No report |
| Pacific Life funds | Against, against management | No report |
| PGIM and Prudential | For | No report |
| PIMCO | Against, against management | No report |
| Principal | Against, against management | No report |
| ProShares and ProFunds | Against, against management | No report |
| SEI | Against, against management | No report |
| State Street and SPDR | Against, against management | No report |
| T. Rowe Price | Against, against management | No report |
| Transamerica | Against, against management | No report |
| Vanguard | Against, against management | No report |
| Victory Capital | Against, against management | No report |
| Virtus | For | No report |
| Voya | Abstain, against management | No report |
Questions
- How many filers reported votes at the ImmunoGen, Inc. meeting?
- 431 Form N-PX filers reported votes at the meeting of 31 Jan 2024. On say-on-pay, 295 of 396 filers that marked the item voted against management (74.5%).
- Is this the result of the meeting?
- No. The page counts the filers that report on Form N-PX, and the shares they reported. ImmunoGen, Inc. reports the result of a vote on Form 8-K.
- Why does the page show counts only for director elections?
- A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list ImmunoGen, Inc. with a meeting date within three days of 31 Jan 2024. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .